Loading…
Ascorbic acid decreases neutral endopeptidase activity in cultured osteoblastic cells
Neprilysin (NEP) is a plasma membrane-bound peptidase with wide expression in kidney, lung, brain and bone. Decreased NEP activity has been linked to increased growth of some cancer cells, but it is unknown whether its activity is related to growth of cells belonging to the osteoblast lineage. We as...
Saved in:
Published in: | Regulatory peptides 2005-08, Vol.130 (1), p.57-66 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c390t-e382923121b26bb8ee5d751556fe3f74f70c94db8a508a88abea62b8a3f2a50c3 |
---|---|
cites | cdi_FETCH-LOGICAL-c390t-e382923121b26bb8ee5d751556fe3f74f70c94db8a508a88abea62b8a3f2a50c3 |
container_end_page | 66 |
container_issue | 1 |
container_start_page | 57 |
container_title | Regulatory peptides |
container_volume | 130 |
creator | Schmid, Christoph Ghirlanda-Keller, Claudia Gosteli-Peter, Martina |
description | Neprilysin (NEP) is a plasma membrane-bound peptidase with wide expression in kidney, lung, brain and bone. Decreased NEP activity has been linked to increased growth of some cancer cells, but it is unknown whether its activity is related to growth of cells belonging to the osteoblast lineage. We assessed NEP activity in an osteoblastic cell line, PyMS, by cleavage of
N-Dansyl-
d-Ala-Gly-
p-nitro-Phe-Gly to Dansyl-
d-Ala-Gly. NEP activity was completely blocked by 1 μM thiorphan. Most agents affecting growth of these cells (e.g. calcium, insulin-like growth factor I and dexamethasone) did not regulate NEP activity. Ascorbic acid (ASA) increased thymidine incorporation into DNA and potentiated the stimulatory effect of IGF I on DNA synthesis, an effect which was attenuated by echistatin. ASA decreased NEP activity in a dose-dependent manner, and decreased Western-detectable NEP protein in plasma membranes. ASA affects both integrin receptor-mediated signalling and the processing of regulatory peptides. |
doi_str_mv | 10.1016/j.regpep.2005.03.007 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68024840</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0167011505001163</els_id><sourcerecordid>68024840</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-e382923121b26bb8ee5d751556fe3f74f70c94db8a508a88abea62b8a3f2a50c3</originalsourceid><addsrcrecordid>eNp9kE1r3DAQhkVpaTZp_0EpvrQ3uyPL-vClEJY0CQRyac5ClsZFi9feauRA_n207EJuOQ0annln9DD2jUPDgatfuybhvwMemhZANiAaAP2BbbjRoubKqI9sUzBdA-fygl0S7QC41Fp8Zhdc9mCgFRv2dE1-SUP0lfMxVAF9QkdI1YxrTm6qcA5L2ZJjKO0C5fgc80sV58qvU14ThmqhjMswOcolxuM00Rf2aXQT4ddzvWJPf27-bu_qh8fb--31Q-1FD7lGYdq-FbzlQ6uGwSDKoCWXUo0oRt2NGnzfhcE4CcYZ4wZ0qi1PMbal5cUV-3nKPaTl_4qU7T7S8QI347KSVeWTnemggN0J9GkhSjjaQ4p7l14sB3vUaXf2pNMedVoQtugsY9_P-euwx_A2dPZXgB9nwJF305jc7CO9capXnTamcL9PHBYbzxGTJR9x9hhiQp9tWOL7l7wCAyuWcg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68024840</pqid></control><display><type>article</type><title>Ascorbic acid decreases neutral endopeptidase activity in cultured osteoblastic cells</title><source>Elsevier</source><creator>Schmid, Christoph ; Ghirlanda-Keller, Claudia ; Gosteli-Peter, Martina</creator><creatorcontrib>Schmid, Christoph ; Ghirlanda-Keller, Claudia ; Gosteli-Peter, Martina</creatorcontrib><description>Neprilysin (NEP) is a plasma membrane-bound peptidase with wide expression in kidney, lung, brain and bone. Decreased NEP activity has been linked to increased growth of some cancer cells, but it is unknown whether its activity is related to growth of cells belonging to the osteoblast lineage. We assessed NEP activity in an osteoblastic cell line, PyMS, by cleavage of
N-Dansyl-
d-Ala-Gly-
p-nitro-Phe-Gly to Dansyl-
d-Ala-Gly. NEP activity was completely blocked by 1 μM thiorphan. Most agents affecting growth of these cells (e.g. calcium, insulin-like growth factor I and dexamethasone) did not regulate NEP activity. Ascorbic acid (ASA) increased thymidine incorporation into DNA and potentiated the stimulatory effect of IGF I on DNA synthesis, an effect which was attenuated by echistatin. ASA decreased NEP activity in a dose-dependent manner, and decreased Western-detectable NEP protein in plasma membranes. ASA affects both integrin receptor-mediated signalling and the processing of regulatory peptides.</description><identifier>ISSN: 0167-0115</identifier><identifier>EISSN: 1873-1686</identifier><identifier>DOI: 10.1016/j.regpep.2005.03.007</identifier><identifier>PMID: 15908023</identifier><identifier>CODEN: REPPDY</identifier><language>eng</language><publisher>Shannon: Elsevier B.V</publisher><subject>Alkaline Phosphatase - metabolism ; Animals ; Ascorbic acid ; Ascorbic Acid - metabolism ; Ascorbic Acid - pharmacology ; Biological and medical sciences ; Blotting, Northern ; Blotting, Western ; Calcium - metabolism ; Cell Membrane - metabolism ; Cell Proliferation ; Cells, Cultured - cytology ; Dexamethasone - pharmacology ; DNA - metabolism ; Dose-Response Relationship, Drug ; Fundamental and applied biological sciences. Psychology ; Growth ; Insulin-Like Growth Factor I - pharmacology ; NEP ; Neprilysin - chemistry ; Neprilysin - pharmacology ; Osteoblasts ; Osteoblasts - cytology ; Osteoblasts - metabolism ; Peptides - chemistry ; Rats ; Signal Transduction ; Subcellular Fractions ; Thiorphan - pharmacology ; Thymidine - chemistry ; Thymidine - metabolism ; Time Factors ; Transcriptional Activation ; Vertebrates: endocrinology</subject><ispartof>Regulatory peptides, 2005-08, Vol.130 (1), p.57-66</ispartof><rights>2005 Elsevier B.V.</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-e382923121b26bb8ee5d751556fe3f74f70c94db8a508a88abea62b8a3f2a50c3</citedby><cites>FETCH-LOGICAL-c390t-e382923121b26bb8ee5d751556fe3f74f70c94db8a508a88abea62b8a3f2a50c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16964788$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15908023$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schmid, Christoph</creatorcontrib><creatorcontrib>Ghirlanda-Keller, Claudia</creatorcontrib><creatorcontrib>Gosteli-Peter, Martina</creatorcontrib><title>Ascorbic acid decreases neutral endopeptidase activity in cultured osteoblastic cells</title><title>Regulatory peptides</title><addtitle>Regul Pept</addtitle><description>Neprilysin (NEP) is a plasma membrane-bound peptidase with wide expression in kidney, lung, brain and bone. Decreased NEP activity has been linked to increased growth of some cancer cells, but it is unknown whether its activity is related to growth of cells belonging to the osteoblast lineage. We assessed NEP activity in an osteoblastic cell line, PyMS, by cleavage of
N-Dansyl-
d-Ala-Gly-
p-nitro-Phe-Gly to Dansyl-
d-Ala-Gly. NEP activity was completely blocked by 1 μM thiorphan. Most agents affecting growth of these cells (e.g. calcium, insulin-like growth factor I and dexamethasone) did not regulate NEP activity. Ascorbic acid (ASA) increased thymidine incorporation into DNA and potentiated the stimulatory effect of IGF I on DNA synthesis, an effect which was attenuated by echistatin. ASA decreased NEP activity in a dose-dependent manner, and decreased Western-detectable NEP protein in plasma membranes. ASA affects both integrin receptor-mediated signalling and the processing of regulatory peptides.</description><subject>Alkaline Phosphatase - metabolism</subject><subject>Animals</subject><subject>Ascorbic acid</subject><subject>Ascorbic Acid - metabolism</subject><subject>Ascorbic Acid - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Blotting, Northern</subject><subject>Blotting, Western</subject><subject>Calcium - metabolism</subject><subject>Cell Membrane - metabolism</subject><subject>Cell Proliferation</subject><subject>Cells, Cultured - cytology</subject><subject>Dexamethasone - pharmacology</subject><subject>DNA - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Growth</subject><subject>Insulin-Like Growth Factor I - pharmacology</subject><subject>NEP</subject><subject>Neprilysin - chemistry</subject><subject>Neprilysin - pharmacology</subject><subject>Osteoblasts</subject><subject>Osteoblasts - cytology</subject><subject>Osteoblasts - metabolism</subject><subject>Peptides - chemistry</subject><subject>Rats</subject><subject>Signal Transduction</subject><subject>Subcellular Fractions</subject><subject>Thiorphan - pharmacology</subject><subject>Thymidine - chemistry</subject><subject>Thymidine - metabolism</subject><subject>Time Factors</subject><subject>Transcriptional Activation</subject><subject>Vertebrates: endocrinology</subject><issn>0167-0115</issn><issn>1873-1686</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp9kE1r3DAQhkVpaTZp_0EpvrQ3uyPL-vClEJY0CQRyac5ClsZFi9feauRA_n207EJuOQ0annln9DD2jUPDgatfuybhvwMemhZANiAaAP2BbbjRoubKqI9sUzBdA-fygl0S7QC41Fp8Zhdc9mCgFRv2dE1-SUP0lfMxVAF9QkdI1YxrTm6qcA5L2ZJjKO0C5fgc80sV58qvU14ThmqhjMswOcolxuM00Rf2aXQT4ddzvWJPf27-bu_qh8fb--31Q-1FD7lGYdq-FbzlQ6uGwSDKoCWXUo0oRt2NGnzfhcE4CcYZ4wZ0qi1PMbal5cUV-3nKPaTl_4qU7T7S8QI347KSVeWTnemggN0J9GkhSjjaQ4p7l14sB3vUaXf2pNMedVoQtugsY9_P-euwx_A2dPZXgB9nwJF305jc7CO9capXnTamcL9PHBYbzxGTJR9x9hhiQp9tWOL7l7wCAyuWcg</recordid><startdate>20050815</startdate><enddate>20050815</enddate><creator>Schmid, Christoph</creator><creator>Ghirlanda-Keller, Claudia</creator><creator>Gosteli-Peter, Martina</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050815</creationdate><title>Ascorbic acid decreases neutral endopeptidase activity in cultured osteoblastic cells</title><author>Schmid, Christoph ; Ghirlanda-Keller, Claudia ; Gosteli-Peter, Martina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-e382923121b26bb8ee5d751556fe3f74f70c94db8a508a88abea62b8a3f2a50c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Alkaline Phosphatase - metabolism</topic><topic>Animals</topic><topic>Ascorbic acid</topic><topic>Ascorbic Acid - metabolism</topic><topic>Ascorbic Acid - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Blotting, Northern</topic><topic>Blotting, Western</topic><topic>Calcium - metabolism</topic><topic>Cell Membrane - metabolism</topic><topic>Cell Proliferation</topic><topic>Cells, Cultured - cytology</topic><topic>Dexamethasone - pharmacology</topic><topic>DNA - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Growth</topic><topic>Insulin-Like Growth Factor I - pharmacology</topic><topic>NEP</topic><topic>Neprilysin - chemistry</topic><topic>Neprilysin - pharmacology</topic><topic>Osteoblasts</topic><topic>Osteoblasts - cytology</topic><topic>Osteoblasts - metabolism</topic><topic>Peptides - chemistry</topic><topic>Rats</topic><topic>Signal Transduction</topic><topic>Subcellular Fractions</topic><topic>Thiorphan - pharmacology</topic><topic>Thymidine - chemistry</topic><topic>Thymidine - metabolism</topic><topic>Time Factors</topic><topic>Transcriptional Activation</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schmid, Christoph</creatorcontrib><creatorcontrib>Ghirlanda-Keller, Claudia</creatorcontrib><creatorcontrib>Gosteli-Peter, Martina</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Regulatory peptides</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schmid, Christoph</au><au>Ghirlanda-Keller, Claudia</au><au>Gosteli-Peter, Martina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ascorbic acid decreases neutral endopeptidase activity in cultured osteoblastic cells</atitle><jtitle>Regulatory peptides</jtitle><addtitle>Regul Pept</addtitle><date>2005-08-15</date><risdate>2005</risdate><volume>130</volume><issue>1</issue><spage>57</spage><epage>66</epage><pages>57-66</pages><issn>0167-0115</issn><eissn>1873-1686</eissn><coden>REPPDY</coden><abstract>Neprilysin (NEP) is a plasma membrane-bound peptidase with wide expression in kidney, lung, brain and bone. Decreased NEP activity has been linked to increased growth of some cancer cells, but it is unknown whether its activity is related to growth of cells belonging to the osteoblast lineage. We assessed NEP activity in an osteoblastic cell line, PyMS, by cleavage of
N-Dansyl-
d-Ala-Gly-
p-nitro-Phe-Gly to Dansyl-
d-Ala-Gly. NEP activity was completely blocked by 1 μM thiorphan. Most agents affecting growth of these cells (e.g. calcium, insulin-like growth factor I and dexamethasone) did not regulate NEP activity. Ascorbic acid (ASA) increased thymidine incorporation into DNA and potentiated the stimulatory effect of IGF I on DNA synthesis, an effect which was attenuated by echistatin. ASA decreased NEP activity in a dose-dependent manner, and decreased Western-detectable NEP protein in plasma membranes. ASA affects both integrin receptor-mediated signalling and the processing of regulatory peptides.</abstract><cop>Shannon</cop><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>15908023</pmid><doi>10.1016/j.regpep.2005.03.007</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0167-0115 |
ispartof | Regulatory peptides, 2005-08, Vol.130 (1), p.57-66 |
issn | 0167-0115 1873-1686 |
language | eng |
recordid | cdi_proquest_miscellaneous_68024840 |
source | Elsevier |
subjects | Alkaline Phosphatase - metabolism Animals Ascorbic acid Ascorbic Acid - metabolism Ascorbic Acid - pharmacology Biological and medical sciences Blotting, Northern Blotting, Western Calcium - metabolism Cell Membrane - metabolism Cell Proliferation Cells, Cultured - cytology Dexamethasone - pharmacology DNA - metabolism Dose-Response Relationship, Drug Fundamental and applied biological sciences. Psychology Growth Insulin-Like Growth Factor I - pharmacology NEP Neprilysin - chemistry Neprilysin - pharmacology Osteoblasts Osteoblasts - cytology Osteoblasts - metabolism Peptides - chemistry Rats Signal Transduction Subcellular Fractions Thiorphan - pharmacology Thymidine - chemistry Thymidine - metabolism Time Factors Transcriptional Activation Vertebrates: endocrinology |
title | Ascorbic acid decreases neutral endopeptidase activity in cultured osteoblastic cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T21%3A49%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ascorbic%20acid%20decreases%20neutral%20endopeptidase%20activity%20in%20cultured%20osteoblastic%20cells&rft.jtitle=Regulatory%20peptides&rft.au=Schmid,%20Christoph&rft.date=2005-08-15&rft.volume=130&rft.issue=1&rft.spage=57&rft.epage=66&rft.pages=57-66&rft.issn=0167-0115&rft.eissn=1873-1686&rft.coden=REPPDY&rft_id=info:doi/10.1016/j.regpep.2005.03.007&rft_dat=%3Cproquest_cross%3E68024840%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c390t-e382923121b26bb8ee5d751556fe3f74f70c94db8a508a88abea62b8a3f2a50c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68024840&rft_id=info:pmid/15908023&rfr_iscdi=true |